Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -4908.21% is 128% below its 5-year average of -2152.39%, around the middle of its 5-year range (-9343.55%–0.00%).
5.04% above its 12-month average of -5168.92%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3072.05%.
OPERATING MARGIN
-4908.21%
OPERATING MARGIN AVG TTM
-5168.92%
OPERATING MARGIN AVG 3Y
-3324.34%
OPERATING MARGIN AVG 5Y
-2152.39%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+5.04%
CURRENT VS 3Y AVG
-47.64%
CURRENT VS 5Y AVG
-128.04%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 598 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Anteris Technologies Global Corp.
Market Cap
$690.35M
Operating Margin
-4908.21%
TTM Avg
-5168.92%
3Y Avg
-3324.34%
5Y Avg
-2152.39%
Market Cap
$703.70M
Operating Margin
19.61%
TTM Avg
25.44%
3Y Avg
21.88%
5Y Avg
18.67%
Market Cap
$678.63M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$712.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$665.40M
Operating Margin
15.26%
TTM Avg
16.07%
3Y Avg
9.54%
5Y Avg
2.83%
Market Cap
$722.78M
Operating Margin
-123601.69%
TTM Avg
-69568.65%
3Y Avg
-35191.57%
5Y Avg
-23714.64%
Market Cap
$655.17M
Operating Margin
317.06%
TTM Avg
-14996.68%
3Y Avg
-12629.31%
5Y Avg
-15360.40%
Market Cap
$650.20M
Operating Margin
-187.24%
TTM Avg
-253932.81%
3Y Avg
-127981.70%
5Y Avg
-85456.42%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anteris Technologies Global Corp. (AVR) | $690.35M | -4908.21% | -5168.92% | -3324.34% | -2152.39% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $703.70M | 19.61% | 25.44% | 21.88% | 18.67% |
| Faeth Therapeutics, Inc. (FTH)vs › | $678.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $712.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| Annexon, Inc. (ANNX)vs › | $666.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| MiMedx Group, Inc. (MDXG)vs › | $665.40M | 15.26% | 16.07% | 9.54% | 2.83% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $722.78M | -123601.69% | -69568.65% | -35191.57% | -23714.64% |
| Helus Pharma Inc. (HELP)vs › | $655.17M | 317.06% | -14996.68% | -12629.31% | -15360.40% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $650.20M | -187.24% | -253932.81% | -127981.70% | -85456.42% |
| Cytek Biosciences, Inc. (CTKB)vs › | $744.51M | -21.60% | -15.14% | -11.45% | -3.99% |
Gross Margin
-16.6%
Operating Margin
-4908.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -3072.05% |
| 2026-03-31 | -4859.72% |
| 2025-12-31 | -9343.55% |
| 2025-09-30 | -5189.98% |
| 2025-06-30 | -3379.29% |
| 2025-03-31 | -3917.27% |
| 2024-12-31 | -3928.70% |
| 2024-09-30 | -2846.20% |
| 2024-06-30 | -2988.29% |
| 2024-03-31 | -2321.80% |
| 2023-12-31 | -2918.91% |
| 2023-09-30 | -1870.07% |
| 2023-06-30 | -2599.83% |
| 2023-03-31 | -1003.36% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
